Co-Authors
This is a "connection" page, showing publications co-authored by GABRIEL LOOR and ANDREW CIVITELLO.
Connection Strength
0.415
-
Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2024 Aug 20.
Score: 0.060
-
Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation. JACC Adv. 2024 May; 3(5):100916.
Score: 0.058
-
Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
Score: 0.058
-
Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
Score: 0.056
-
Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
Score: 0.051
-
Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
Score: 0.048
-
Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
Score: 0.046
-
Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol. 2018 02 01; 121(3):336-342.
Score: 0.038